Astrana Health, Inc.
ASTH
$30.37
-$1.03-3.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.15M | 62.46M | 68.42M | 62.42M | 60.72M |
| Total Depreciation and Amortization | 27.93M | 24.70M | 21.74M | 18.55M | 17.75M |
| Total Amortization of Deferred Charges | 1.83M | 1.72M | 1.50M | 1.28M | 1.06M |
| Total Other Non-Cash Items | 42.91M | 11.04M | 18.76M | 11.83M | 12.09M |
| Change in Net Operating Assets | -63.61M | -17.48M | -46.56M | -27.60M | -23.39M |
| Cash from Operations | 52.20M | 82.45M | 63.87M | 66.48M | 68.23M |
| Capital Expenditure | -8.03M | -12.56M | -14.37M | -14.05M | -28.53M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -146.26M | -117.33M | -121.45M | -57.16M | -6.51M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.10M | -40.61M | -61.45M | -51.32M | -30.48M |
| Cash from Investing | -192.40M | -170.50M | -197.27M | -122.53M | -65.52M |
| Total Debt Issued | 171.88M | 453.25M | 453.11M | 392.91M | 284.53M |
| Total Debt Repaid | -27.71M | -219.67M | -216.10M | -208.73M | -205.36M |
| Issuance of Common Stock | 1.03M | 775.00K | 272.00K | 272.00K | 1.52M |
| Repurchase of Common Stock | -5.60M | -5.20M | -4.24M | -653.00K | -10.19M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -59.81M | -62.07M | -62.07M | -62.07M |
| Other Financing Activities | -4.44M | -6.95M | -5.89M | -4.86M | -5.01M |
| Cash from Financing | 135.15M | 162.41M | 165.09M | 116.87M | 3.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.05M | 74.35M | 31.69M | 60.83M | 6.13M |